Match!
Ryosuke Sakai
Kyoto Prefectural University of Medicine
EndocrinologyCohort studyType 2 diabetesDiabetes mellitusMedicine
14Publications
2H-index
20Citations
What is this?
Publications 18
Newest
#1Takuro Okamura (Kyoto Prefectural University of Medicine)H-Index: 3
#2Yoshitaka Hashimoto (Kyoto Prefectural University of Medicine)H-Index: 10
Last. Masahiro Yamazaki (Kyoto Prefectural University of Medicine)H-Index: 17
view all 11 authors...
Source
#1Yoshitaka Hashimoto (Kyoto Prefectural University of Medicine)H-Index: 10
#2Ayumi Kaji (Kyoto Prefectural University of Medicine)H-Index: 2
Last. Michiaki Fukui (Kyoto Prefectural University of Medicine)H-Index: 33
view all 8 authors...
Abstract Background & Aims The association between skipping breakfast and glycemic parameters, including glycemic variability, in patients with type 2 diabetes is unknown. Therefore, we investigated the impact of skipping breakfast on glycemic parameters, including glycemic variability, in patients with type 2 diabetes. Methods In this cross-sectional study, we assessed lifestyle factors, including skipping breakfast using a questionnaire method. We calculated the average, standard deviation (SD...
Source
#1Ryosuke Sakai (Kyoto Prefectural University of Medicine)H-Index: 2
#2Yoshitaka Hashimoto (Kyoto Prefectural University of Medicine)H-Index: 10
Last. Michiaki Fukui (Kyoto Prefectural University of Medicine)H-Index: 33
view all 9 authors...
Source
#1Yoshitaka HashimotoH-Index: 10
#2Masahide HamaguchiH-Index: 22
Last. Michiaki FukuiH-Index: 33
view all 11 authors...
Background: There is a close association between gut dysbiosis and type 2 diabetes (T2D). However, little is known about gut dysbiosis in Japanese patients with T2D and the association between gut dysbiosis and habitual dietary intake is also unknown. Methods: In this cross-sectional study, 97 patients with T2D and 97 subjects without T2D matched by age and sex were selected. We obtained 16S rRNA metagenomic data from fecal samples. Habitual dietary intake of patients with T2D was evaluated by b...
Source
#1Takuro Okamura (Kyoto Prefectural University of Medicine)H-Index: 3
#2Akane Miki (Kyoto Prefectural University of Medicine)H-Index: 3
Last. Michiaki Fukui (Kyoto Prefectural University of Medicine)H-Index: 33
view all 9 authors...
2 CitationsSource
#1Ayumi KajiH-Index: 2
#2Yoshitaka HashimotoH-Index: 10
Last. Michiaki FukuiH-Index: 33
view all 9 authors...
Previous studies have revealed that the density of convenience stores in the neighborhood was associated with chronic diseases. In Japan, convenience stores are more common, and it is thus more important to assess whether people use convenience stores than the density or availability of the convenience stores. In this cross-sectional study of patients with type 2 diabetes, the association between the usage of the convenience stores and dietary habits or the prevalence of hypertension was evaluat...
Source
#1Ryosuke Sakai (Kyoto Prefectural University of Medicine)H-Index: 2
#2Yoshitaka Hashimoto (Kyoto Prefectural University of Medicine)H-Index: 10
Last. Michiaki Fukui (Kyoto Prefectural University of Medicine)H-Index: 33
view all 8 authors...
1 CitationsSource
#1Ayumi Kaji (Kyoto Prefectural University of Medicine)H-Index: 2
#2Yoshitaka Hashimoto (Kyoto Prefectural University of Medicine)H-Index: 10
Last. Michiaki Fukui (Kyoto Prefectural University of Medicine)H-Index: 33
view all 10 authors...
Source
#1Takuro Okamura (Kyoto Prefectural University of Medicine)H-Index: 3
#2Yoshitaka Hashimoto (Kyoto Prefectural University of Medicine)H-Index: 10
Last. Michiaki Fukui (Kyoto Prefectural University of Medicine)H-Index: 33
view all 13 authors...
Source
#1Michitsugu Kamezaki (Kyoto Prefectural University of Medicine)H-Index: 2
#2Tetsuro Kusaba (Kyoto Prefectural University of Medicine)H-Index: 11
Last. Keiichi Tamagaki (Kyoto Prefectural University of Medicine)H-Index: 9
view all 17 authors...
Clinical and experimental studies have shown that sodium glucose co-transporter 2 inhibitors (SGLT2i) contribute to the prevention of diabetic kidney disease progression. In order to clarify its pharmacological effects on the molecular mechanisms underlying the development of diabetic kidney disease, we administered different doses of the SGLT2i, ipragliflozin, to type 2 diabetic mice. A high-dose ipragliflozin treatment for 8 weeks lowered blood glucose levels and reduced urinary albumin excret...
6 CitationsSource
12